| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.0085 | 1 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.0082 | 1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |